Cytokinetics Inc share price logo

Cytokinetics Inc Share Price

NASDAQ: CYTK

Mid Cap

$47.54

-0.02

(-0.04%)

Live

as on

Cytokinetics Inc Stock Performance

as on September 18, 2025 at 9:38 pm IST

  • Day's Low

    Day's High

    $47.34
    $48.72
    downward going graph

    0.42%

    Downside

    2.48%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $29.31
    $59.39
    downward going graph

    38.35%

    Downside

    24.93%

    Upside

    downward going graph

Cytokinetics Inc share price movements today

Previous Close
$47.56
Open
$48.46
Volume
852.6K
Day's Low - High
$47.34 - $48.72
52 Week Low - High
$29.31 - $59.39

Cytokinetics Inc Historical Returns

1 Month Return
+ 22.11 %
3 Month Return
+ 45.31 %
1 Year Return
-14.98 %
3 Year Return
-10.85 %
5 Year Return
+ 118.12 %

Cytokinetics Inc Stock Fundamentals & Key Indicators

Check Cytokinetics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.7B

EPS (TTM)

-5.6178

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-12.38

Industry PE ratio

10.127857142857144

P/B Ratio

0

PEG Ratio

-0.42

EBITDA

-537.6M

Revenue (TTM)

85.7M

Profit Margin

0.00%

Return On Equity TTM

151500.00%

Cytokinetics Inc Stock Valuation

Track how Cytokinetics Inc P/E has moved over time to understand its valuation trends.

Cytokinetics Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 18, 2025

Today (-12.38x)

September 18, 2025

Industry (10.13x)

September 18, 2025

Highest (0.00x)

September 18, 2025

LowHigh

Today’s Price to Earnings Ratio: -12.38x

Cytokinetics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cytokinetics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$5.7B118.12%-12.380.00%
BUY$60.5B241.54%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$99.3B45.88%27.5631.86%
BUY$60.9B5.45%14.4931.37%

Stock Returns calculator for Cytokinetics Inc Stock including INR - Dollar returns

The Cytokinetics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cytokinetics Inc investment value today

Current value as on today

₹89,937

Returns

₹10,063

(-10.06%)

Returns from Cytokinetics Inc Stock

₹15,016 (-15.02%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Cytokinetics Inc Stock

Based on 25 analysts

BUY

84.00%

Buy

16.00%

Hold

0.00%

Sell

Based on 25 analysts, 84% of analysts recommend a 'BUY' rating for Cytokinetics Inc. Average target price of $74.41

Cytokinetics Inc Share Price Target

Get share price movements and forecasts by analysts on Cytokinetics Inc.

What analysts predicted

36.11%UPSIDE

Target Price

$74.41

Current Price

$47.54

Analyzed by

25 Analysts

Target

$74.41

Cytokinetics Inc target price $74.41, a slight upside of 36.11% compared to current price of $47.54. According to 25 analysts rating.

Cytokinetics Inc Stock's Interest Amongst Investors

Investment in Cytokinetics Inc Shares on INDmoney has grown by 362.50% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:362.50% versus previous 30 day period

Search interest for Cytokinetics Inc Stock has increased by 223% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:223% versus previous 30 day period

Cytokinetics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
4
0
0
1
0
0
0
16
1
66
Gross Profit
-74
-82
-82
-83
-80
-79
-84
-76
-98
64
Operating Income
-124
-122
-122
-127
-126
-130
-140
-139
-155
-111
EBITDA
-115
-112
-113
-113
-115
-116
-135
-125
-136
-107
Interest Expense
13
13
13
17
17
24
22
22
22
24
Depreciation
1
1
1
6
2
2
2
2
2
2
Income Before Tax
-131
-128
-129
-136
-135
-143
-160
-150
-161
-134
Income Tax Expense
-1
6
6
1
2
-
-
-
-
-
Net Income
-131
-128
-129
-136
-135
-143
-160
-150
-161
-134
Net Profit Margin
-2846.07%
-14837.02%
-34238.62%
-8187.56%
-16244.67%
-57557.43%
-34674.95%
-886.28%
-10220.14%
-201.25%

Cytokinetics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
28
106
13
31
26
55
70
94
7
18
Gross Profit
-17
46
-76
-57
-59
-41
-89
-146
-322
-320
Operating Income
-37
18
-113
-88
-98
-93
-186
-324
-496
-536
EBITDA
-36
19
-108
-83
-93
-86
-176
-329
-456
-493
Interest Expense
0
2
16
21
27
38
29
51
57
86
Depreciation
-
-
1
1
1
1
2
5
7
9
Income Before Tax
-37
16
-127
-106
-121
-127
-215
-388
-526
-589
Income Tax Expense
0
0
0
4
27
36
27
13
11
-
Net Income
-37
16
-127
-106
-121
-127
-215
-388
-526
-589
Net Profit Margin
-130.86%
15.46%
-955.94%
-337.41%
-452.93%
-228.00%
-305.72%
-411.21%
-6988.63%
-3191.11%

Cytokinetics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-128
-129
-136
-135
-143
-160
-150
-161
-134
Operating Cash Flow
-121
-96
-74
-129
-99
-101
-65
-131
-128
Investing Cash Flow
82
73
-81
32
-651
-45
110
105
52
Financing Cash Flow
5
54
168
103
821
3
2
4
78
Change in Cash
-34
31
13
6
70
-143
47
-21
2

Cytokinetics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
16
-127
-106
-121
-127
-215
-388
-526
-589
Operating Cash Flow
36
-101
-101
-90
8
-142
-299
-414
-395
Investing Cash Flow
-52
-65
5
-74
-196
-147
-262
239
-553
Financing Cash Flow
16
225
13
159
234
319
516
221
930
Change in Cash
1
58
-82
-5
46
29
-45
46
-18

Global Institutional Holdings in Cytokinetics Inc

Funds
Holdings
BlackRock Inc
13.01%
Vanguard Group Inc
9.91%
FMR Inc
8.63%
T. Rowe Price Investment Management,Inc.
8.32%
Wellington Management Company LLP
6.68%

Cytokinetics Inc News & Key Events

  • img

    Today's Timeline - 17 September

    Wed, 09:30 PM

    -

    Cytokinetics stock fell over 1% after announcing $650 million convertible senior notes due in 2031.

Insights on Cytokinetics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.57M → 66.76M (in $), with an average increase of 97.6% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -161.37M → -134.37M (in $), with an average increase of 20.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 83.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 122.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CYTK stock has moved down by -10.8%

About Cytokinetics Inc

cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. as a leader in muscle biology and the mechanics of muscle performance, we're developing small molecule drug candidates specifically engineered to increase muscle function and contractility.
OrganisationCytokinetics Inc
Headquarters350 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
IndustryHealth Technology
CEOMr. Robert I. Blum
E-voting on sharesClick here to vote

Key Management of Cytokinetics Inc

Name

Title

Ms. Kari K. Loeser J.D.

VP & Chief Compliance Officer

Mr. John O. Faurescu Esq., J.D.

Senior VP, Deputy General Counsel & Corporate Secretary

Mr. Robert I. Blum

CEO, President & Director

Dr. James A. Spudich Ph.D.

Co-Founder & Member of Scientific Advisory Board

Ms. Holly Laughlin

VP of Accounting & Corporate Controller

Mr. Steven M. Cook J.D.

Senior Vice President of Global Supply Chain Operations & Technical Operations

Mr. Sung H. Lee

EVP & CFO

Dr. Fady Ibraham Malik FACC, M.D., Ph.D.

Executive Vice President of Research & Development

Mr. Andrew M. Callos

Executive VP & Chief Commercial Officer

Mr. Jeff Lotz

Vice President of Sales & Operations

FAQs

What is Cytokinetics Inc share price today?

Cytokinetics Inc share price today is $47.54 as on . Cytokinetics Inc share today touched a day high of $48.72 and a low of $47.34.

What is the 52 week high and 52 week low for Cytokinetics Inc share?

Cytokinetics Inc share touched a 52 week high of $59.39 on and a 52 week low of $29.31 on . Cytokinetics Inc stock price today i.e. is trending at $47.54,which is 19.95% down from its 52 week high and 62.20% up from its 52 week low.

What is Cytokinetics Inc's market capitalisation today?

Cytokinetics Inc market capitalisation is $0.01T as on .

How to invest in Cytokinetics Inc Stock (CYTK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cytokinetics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cytokinetics Inc Shares that will get you 0.0316 shares as per Cytokinetics Inc share price of $47.54 per share as on September 18, 2025 at 9:38 pm IST.

What is the minimum amount required to buy Cytokinetics Inc Stock (CYTK) from India?

Indian investors can start investing in Cytokinetics Inc (CYTK) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Cytokinetics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Cytokinetics Inc share’s latest price of $47.54 as on September 18, 2025 at 9:38 pm IST, you will get 0.2103 shares of Cytokinetics Inc. Learn more about fractional shares .

What are the returns that Cytokinetics Inc has given to Indian investors in the last 5 years?

Cytokinetics Inc stock has given 118.12% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?